This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. Dr. Aileen Marty, Infectious Disease ...
UPDATE: The U.S. is recommending a “pause” in administration of the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots. In a joint statement ...
The Food and Drug Administration (FDA) announced Thursday the approval of both Pfizer’s and Moderna’s updated COVID-19 vaccines for the 2024-2025 respiratory viral season. The updated vaccines are ...
The packing and shipping of a third COVID-19 vaccine approved for use in the U.S. is underway. Johnson & Johnson’s single-dose shot will start going into Americans’ arms in a matter of days. Nearly 4 ...
Moderna COVID-19 vaccines were associated with a threefold increased risk of chronic urticaria and nearly fourfold increased risk of other types of urticaria compared to expected rates.
Both the CEOs of Moderna and Pfizer said a booster dose of their respective COVID-19 vaccines could be required as soon as September for those who were among the earliest vaccinated. During an Axios ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results